Ciprofloxacin
Product Images NDC 13107-077

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 13107-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label.principal Display Panel (250 MG (1000 TABLETS BOTTLE))

Package Label.principal Display Panel (250 MG (1000 TABLETS BOTTLE))
Ciprofloxacin Tablets are a medication that contains 250mg of ciprofloxacin USP in each film coated tablet. The usual dosage and administration are indicated in the package insert. They should be stored at 20° to 25°C and can be kept at 15° to 30°C occasionally. It is recommended to refer to the USP Controlled Room Temperature. This product is available in batches and is valid until a stated expiration date. This medication is exclusively available through prescription and comes in a pack of 1000 tablets. Medication guide is to be provided separately. The manufacturer of this product is Aurobindo Pharma USA, Inc. and is manufactured by Aurolife Pharma, LLC in Dayton, NJ 08810.*
FDA Label Image

Package Label.principal Display Panel (500 MG (1000 TABLETS BOTTLE))

Package Label.principal Display Panel (500 MG (1000 TABLETS BOTTLE))
Ciprofloxacin Tablets, USP are a medication in tablet form containing 500mg of ciprofloxacin hydrochloride. The package insert contains information on the usual dosage and administration of the drug. They should be stored at a controlled room temperature between 20°C to 25°C and permitted excursions to 15°C to 30°C. The medicine is dispensed with a medication guide provided separately by a pharmacist. The tablets are produced by Aurolife Pharma and manufactured for Aurobindo Pharma USA, and have a batch and an expiry date mentioned as LM-079, and the revised date is April 2009.*
FDA Label Image

Ciprofloxacin Structure (Ciprofloxacin Str1)

Ciprofloxacin Structure (Ciprofloxacin Str1)
FDA Label Image

Ciprofloxacin Structure 2 (Ciprofloxacin Str2)

Ciprofloxacin Structure 2 (Ciprofloxacin Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.